Teva to advance TEV-'408 into Phase 2b study in vitiligo in Q4

See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corporate executives informed on what's moving stocks. Sign up for a free trial at thefly.com to see what Wall Street is buzzing about.